Genome-based biomarkers for adverse drug effects, patient enrichment and prediction of drug response, and their incorporation into clinical trial design

Author： White Thomas J   Clark Andrew G   Broder Samuel  

Publisher： Future Medicine

ISSN： 1741-0541

Source： Personalized Medicine, Vol.3, Iss.2, 2006-05, pp. : 177-185

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biomarkers in Transplantation Medicine: Prediction of Pharmacodynamic Drug Effects

By  

Transfusion Medicine and Hemotherapy, Vol. 34, Iss. 3, 2007-05 ,pp. : 182-187

Karger

Access to resources Recommend Favorite

In Silico Prediction of Adverse Drug Reactions and Toxicities Based on Structural, Biological and Clinical Data

By  

Current Drug Safety, Vol. 7, Iss. 3, 2012-09 ,pp. : 225-237

Bentham Science Publishers

Access to resources Recommend Favorite

A prediction model‐based algorithm for computer‐assisted database screening of adverse drug reactions in the Netherlands

By  

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol. 27, Iss. 2, 2018-02 ,pp. : 199-205

John Wiley & Sons Inc

Access to resources Recommend Favorite

Critical Thinking about Adverse Drug Effects: Lessons from the Psychology of Risk and Medical Decision-Making for Clinical Psychopharmacology

By  

Psychotherapy and Psychosomatics, Vol. 77, Iss. 4, 2008-04 ,pp. : 201-208

Karger

Access to resources Recommend Favorite

Genome-Based Phylogeny of Poxvirus

By  

Intervirology, Vol. 49, Iss. 4, 2006-05 ,pp. : 207-214

Karger

Access to resources Recommend Favorite